Dual-pathway support for lasting weight loss.
For some patients, weight loss resists every diet plan and willpower strategy — because the real problem is biology, not effort. Tirzepatide is a newer class of medication that works on two hormone pathways at once (GLP-1 and GIP), helping regulate appetite, fullness, and how your body processes food. Our physician-guided program pairs the medication with proper evaluation, careful dosing, and follow-up that supports you for the long haul.
What is Tirzepatide?
GLP-1 and GIP Receptor Agonist
Tirzepatide is a prescription medication used as part of a physician-guided weight-loss program. Unlike single-pathway GLP-1 medications, tirzepatide activates two hormone receptors — GLP-1 and GIP — which work together to regulate appetite, fullness, and how your body processes food. Patients typically combine treatment with improved nutrition and activity for the most durable results.
Backed by Recent Clinical Research
Tirzepatide is among the newer additions to the medical weight-loss toolbox, supported by the SURMOUNT Phase 3 clinical trial program involving more than 5,000 participants. In head-to-head research published in the New England Journal of Medicine, tirzepatide produced greater average weight loss than other leading options — though individual response varies, and not every patient is a candidate.
Why Tirzepatide?
Works On Two Pathways
Tirzepatide targets both GLP-1 and GIP receptors — two hormones that regulate appetite and metabolism. This dual-action approach is what sets tirzepatide apart from single-pathway GLP-1 options and may help some patients see stronger results.
Designed for Steady Progress
Rather than rapid, short-term weight loss, tirzepatide supports gradual, consistent progress over months. For many patients, this pace feels more sustainable — and is often associated with better long-term outcomes than crash approaches.
Fits Into Real Life
A simple once-weekly injection means no daily pills, no complicated schedules, and no overly restrictive plans to maintain. For patients with busy lives, this routine tends to be easier to stick with over time.
Built Around Your Biology
Tirzepatide may help reduce appetite and support better control over day-to-day hunger, making it easier for some patients to stay consistent with their plan.
By the Numbers
at 72 weeks
5% body-weight loss
Reduction
SIMPLE. STRUCTURED. CATERED.
What Treatment Can Look Like
A Personalized Starting Point
Every patient begins with a comprehensive review of health history, lab work when indicated, and weight-loss goals. This step determines whether tirzepatide is appropriate for you — and helps identify any conditions that would make it unsafe.
A Consistent Weekly Rhythm
Tirzepatide is a once-weekly injection you'll do at home, typically on the same day each week. For most patients, the routine becomes automatic within a month and fits cleanly into a busy life.
Adjustments Over Time
Your dose, support, and goals evolve as you progress. Regular check-ins let our team refine your treatment plan based on how you're responding — rather than applying a one-size-fits-all protocol.
Is this program right for you?
You're likely a good candidate if:
This program is not appropriate if you have:
Frequently Asked Questions
Safety Information You Should Know
⚠ Risk of Thyroid C-Cell Tumors
In animal studies, tirzepatide caused thyroid tumors, including medullary thyroid carcinoma (MTC). It is not known whether tirzepatide causes these tumors in humans. Do not use tirzepatide if you or any family member has ever had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Tirzepatide is the active ingredient in FDA-approved medications for chronic weight management and type 2 diabetes (Zepbound and Mounjaro), and has been studied extensively through the SURMOUNT clinical trial program. Our program uses compounded tirzepatide, prepared by licensed U.S. compounding pharmacies. Like any prescription medication, it carries potential risks — here's everything our medical team screens for before prescribing.
Contraindications
Do not take semaglutide if you:
Common Side Effects
Most side effects improve as your body adjusts to the medication, especially during dose increases. Our team starts every patient on a low dose and titrates up slowly to minimize discomfort.
Every patient in our program receives:
- A thorough medical history review before any prescription is written
- Lab work when clinically indicated
- Regular provider check-ins throughout your treatment
- Direct access to our medical team for questions or concerns
- Medication sourced only from licensed, FDA-registered compounding pharmacies
We'd rather turn away a patient who isn't a good fit than put anyone at unnecessary risk. If tirzepatide isn't right for you, we'll tell you — and help you explore other options.
Research & Clinical Srouces
All of the studies above were funded by Eli Lilly, the manufacturer of tirzepatide. This is standard practice for pharmaceutical drug development and does not invalidate the findings — all studies were published in peer-reviewed journals after independent review — but it is worth noting for transparency. Individual patient results may differ from clinical trial averages, which is why our program includes thorough medical evaluation and ongoing monitoring for every patient.